Hayvan Sağlığı Araştırmaları 2009 Yılı Program - Tagem

20. Aucouturier, J., Dupuis, L., Ganne, V., “Adjuvants designed for veterinary and human
vaccines”, Vaccine, 19: 2666-2672 (2001).
21. Lindblad, E.B., “Aluminium adjuvants”, The theory and practical application of adjuvants.
Stewart-Tull DES, JohnWiley & Sons Ltd., New York, 21-35 (1995).
22. Allison, A.C., Byars, N.E., Immunological Adjuvants: Desirable Properties and Side-effects”,
Molecular Immunology, 28 (3): 279-284 (1991).
23. Donnely, J.J., “New developments in adjuvants”, Mechanisms of Ageing and Development,
93:171-177 (1997).
24. Lubben, I.M., Verhoef, J.C., Borchard, G., Junginger, H.E., “Chitosan and its derivatives in
mucosal drug and vaccine delivery”, European Journal of Pharmaceutical Sciences, 14: 201-
207 (2001).
25. Dutta, P.D., Ravikumar, M.N.V., Dutta, J., “Chitin And Chitosan For Versatile Applications”,
Journal of Macromolecular Science, Part C—Polymer Reviews, C42 (3): 307-354 (2002).
26. ������� ������ ������� ���� ��������� ��� ���������� ��������� ��������������� Veteriner Cerrahi
Dergisi, 10 (3-4): 62-72 (2004).
27. Illum, L., “Chitosan and its use as a pharmaceutical excipient”, Pharm. Res., 15: 1326-1331
(1998).
28. Singla, A.K., Chawla, M., “Chitosan: some pharmaceutical and biological aspects-an update”,
J.Pharm. Pharmacol., 53: 1047-1067 (2001).
29. Onishi, H., Machida, Y., “Biodegradation and distribution of water-soluble chitosan in mice”,
Biomaterials, 20: 175-182 (1999).
30. Rao, S.B., Sharma, C.P., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic
potential”, J. Biomed. Mater. Res., 34: 21-28 (1997).
31. Ravikumar, M.N.V., “A review of chitin and chitosan applications”, Reactive and Functional
Polymers, 46: 1-27 (2000).
32. Shigemasa, Y., Minami, S., “Applications of chitin and chitosan for biomaterials”,
Biotechnology and Genetic Engineering Reviews, 13: 383-420 (1995).
33. Khor, E., “Chitin: a biomaterial in waiting”, Current Opinion in Solid State and Materials
Science, 6: 313-317 (2002).
34. Sabnis, S., Block, L.H., “Chitosan as an enabling excipient for drug delivery systems I.
Molecular modifications”, International Journal of Biological Macromolecules, 27: 181-186
(2000).
35. Kurita, K., “Chitin and Chitosan: Functional Biopolymers from Marine Crustaceans”, Marine
Biotechnology, 8: 203-226 (2006).
36. Koide, S.S., “Chitin-Chitosan: Properties, Benefits and Risks”, Nutrition Research, 18 (6):
1091-1101 (1998).
37. Prashanth, K.V.H., Tharanathan, R.N., “Chitin/chitosan: modifications and their unlimited
application potential-an overview”, Trends in Food Science and Technology, 18: 117-131
(2007).
38. Martinoa, A.D., Sittingerc, M., Risbuda, M.V., “Chitosan: A versatile biopolymer for
orthopaedic tissue-engineering”, Biomaterials, 26: 5983-5990 (2005).
39. Lubben, I.M., Verhoef, J.C., Borchard, G., Junginger, H.E., “Chitosan for mucosal
vaccination”, Advanced Drug Delivery Reviews, 52: 139-144 (2001).
40. Ueno, H., Mori, T., Fujinaga, T., “Topical formulations and wound healing applications of
Chitosan”, Advanced Drug Delivery Reviews, 52: 105-115 (2001).
41. Soane, R.J., Frier, M., Perkins, A.C., Jones, N.S., Davis, S.S., Illum, L., “Evaluation of the
clearance characteristics of bioadhesive systems in humans”, International Journal of
Pharmaceutics, 178: 55-65 (1999).
42. Borchard, G., “Chitosans for gene delivery”, Advanced Drug Delivery Reviews, 52: 145-150
(2001).
43. Apple, R.J., Domen, P.L., Muckerheide, A., Michael, J.G., “Cationization of protein antigens
IV. Increased Antigen Uptake by Antigen Presenting Cells”, The Journal of Immunology, 140
(10): 3290-3295 (1998).
44. Seferian, P.G., Martinez M.L., “Immune stimulating activity of two new chitosan containing
adjuvant formulations”, Vaccine, 19: 661-668 (2001).
331